MIA's Zenobia Morrill interviews Lucy Johnstone about the reaction to the Power Threat Meaning Framework, her life influences, and her hopes for the future.
The Resilience Investment, Support, and Expansion (RISE) From Trauma Act, legislation designed to increase support for children who have been exposed to Adverse Childhood Experiences, includes $50 million in funding for a “mental health in schools” program. Exactly what these programs would entail remains unclear.
MIA's Gavin Crowell-Williamson interviews PharmedOut founder Dr. Adriane Fugh-Berman about Big Pharma's influence on medical education.
MIA's Peter Simons interviews David Cohen, PhD, on his path to researching mental health, coercive practices, and discontinuation from psychiatric drugs.
Akansha Vaswani interviews Dr. John Read about the influences on his work and his research on madness, psychosis, and the mental health industry.
Dr. Raskin discusses psychotherapists’ dissatisfaction with current psychiatric diagnostic systems and explores alternatives.
Dr. Vance Trudeau discusses his study's finding that antidepressants may have far-reaching, adverse effects that last up to three generations.
Peer-Support Groups Were Right, Guidelines Were Wrong: Dr. Mark Horowitz on Tapering Off Antidepressants
In an interview with MIA, Dr. Horowitz discusses his recent article on why tapering off antidepressants can take months or even years.
Dr. Gail Hornstein, author of Agnes’s Jacket: A Psychologist’s Search for the Meanings of Madness, discusses the importance of personal narratives and service-user activism in the context of the global mental health movement.
The published report of the Broaden Trial of Deep Brain Stimulation for Depression whitewashed the results: although the efficacy results were negative, the investigators concluded that the therapy still showed "promise", and adverse events suffered by the patients were downplayed or attributed to the disease, and not the treatment. An in-depth investigation of how the trial results were spun, and interviews with patients that tell of harm done.
When Carina Håkansson sent out an invitation for a symposium on "Pharmaceuticals: Risks and Alternatives," some of the world's top scientists, along with experts-by-experience, came from 13 countries to explore better ways to respond to people in crisis.